Videoconference-delivered group cognitive behavioral stress management for ME/CFS patients who present with severe PEM: A randomized controlled trial Journal Article


Authors: May, M.; Milrad, S. F.; Perdomo, D. M.; Czaja, S. J.; Jutagir, D. R.; Hall, D. L.; Klimas, N.; Antoni, M. H.
Article Title: Videoconference-delivered group cognitive behavioral stress management for ME/CFS patients who present with severe PEM: A randomized controlled trial
Abstract: Background: In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), post-exertional malaise (PEM) is associated with greater distress and symptoms. Cognitive Behavioral Stress Management (CBSM) has demonstrated beneficial effects for ME/CFS and may mitigate stress-related triggers of PEM. We tested a virtual CBSM intervention to increase access, and we report on its effects on stress and symptoms in ME/CFS patients with severe PEM. Methods: Data were from a randomized controlled trial (NCT01650636) comparing 10-week videoconference-delivered group CBSM (V-CBSM, n = 75) to a 10-week Health Information active control (V-HI, n = 75) in Fukuda criteria ME/CFS patients (71 classified as highPEM, 79 lowPEM). Linear regression explored PEM-by-Treatment interactions on overall symptom frequency and intensity, perceived stress, and fatigue-specific interference and intensity, at 5-month follow-up. Logistic regression tested V-CBSM effects on 5-month PEM status. Analyses controlled for age, gender, race/ethnicity, mode of symptom onset, and time since diagnosis. Results: The sample was middle-aged (47.96 ± 10.89 years), mostly women (87%) and non-Hispanic White (65%), with no group differences on these variables or baseline PEM. For highPEM patients, V-CBSM (versus V-HI) demonstrated medium to large effects on follow-up symptom frequency, symptom intensity, fatigue interference, and fatigue intensity (p’s <.05) and trending to significant reductions in perceived stress (p =.07). Differences were not evident for lowPEM patients. Treatment predicted follow-up PEM status at a trend (p =.058), with patients receiving V-CBSM demonstrating half the risk of highPEM classification versus V-HI. Conclusions: V-CBSM demonstrates benefits for ME/CFS patients presenting with severe PEM and may reduce the expression of PEM over time. Trial registration: ClinicalTrials.gov identifier: NCT01650636. © 2024 IACFS/ME.
Keywords: adult; controlled study; aged; middle aged; major clinical study; fatigue; follow up; analysis; phenotype; quality of life; randomized controlled trial; malaise; social support; depression; cytokine; distress syndrome; cognitive defect; rheumatoid arthritis; corticosteroid; awareness; exploratory analysis; mood disorder; cognitive behavioral stress management; chronic fatigue syndrome; confounding variable; fatigue symptom inventory; short portable mental status questionnaire; human; male; female; article; hyperpnea; sociodemographics; assessment of humans; cognitive restructuring; post-exertional malaise; myalgic encephalomyelitis; videoconferencing; perceived stress scale; confusion matrix
Journal Title: Fatigue: Biomedicine, Health and Behavior
Volume: 12
Issue: 2
ISSN: 2164-1846
Publisher: Taylor & Francis Group  
Date Published: 2024-01-01
Start Page: 101
End Page: 122
Language: English
DOI: 10.1080/21641846.2024.2306801
PROVIDER: scopus
PMCID: PMC11086677
PUBMED: 38736736
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Devika Ruth Jutagir
    29 Jutagir